Today on the blog we share the latest information about monkeypox virus and discuss how effective Clinell products are at killing it.
Monkeypox is a viral infection caused by an enveloped virus which belongs to the Orthopoxvirus genus in the family Poxviridae.
Although the role of surfaces in the transmission of the virus is unclear, GAMA Healthcare have received several enquiries about the efficacy of Clinell products.
Whilst test data specific to the Monkeypox virus has not been submitted to TGA, Clinell Universal Wipes have been tested against non-enveloped viruses, including Norovirus by independent laboratories. Clinell Universal Wipes produce a 4-log reduction (99.99% kill) against Norovirus in a 60 second contact time.
As a non-enveloped virus, the core of a Norovirus is protected by a protein shield called a capsid. The capsid is both essential for viral infection and provides protection against disinfection. Despite this protection, Clinell Universal Wipes are still efficacious against Norovirus.
By contrast, as an enveloped virus Monkeypox virus still has a capsid, but it is held inside a viral envelope. The envelope is made of a membrane called a lipid bilayer and is essential for viral infection. Because of this, enveloped viruses are much more susceptible to disinfectants. Once the lipid bilayer is broken, the virus is no longer infectious, even if the capsid is intact.
Furthermore, Clinell Universal Wipes contain Quaternary Ammonium Compounds (QACs) which have incredibly good activity against lipid bilayers.
Because of this, efficacy against non-enveloped viruses, like Norovirus, is sufficient to also demonstrate efficacy against enveloped viruses, like Monkeypox virus.
Typically, monkeypox infections are found in Central and Western African countries such as Nigeria, Liberia and Democratic of Congo. However, in the past few weeks, cases have been reported in Portugal, Spain the UK and Australia.
According to UKSHA, initial symptoms of monkeypox include fever, headache, muscle aches, backache, swollen lymph nodes, chills and exhaustion. A rash can develop, often beginning on the face, then spreading to other parts of the body including the genitals.
The infection is usually spread by close contact with an infected patient, however there is a very low risk of transmission to the general public. The sources of identified cases are being rapidly investigated by UKHSA and they are raising awareness among health professionals.
The emerging character of the disease has been attributed to:
Higher or more frequent exposure to animal reservoir species
Increased human-to-human transmission rate
Advances in diagnostic capacity and health education
The cessation of the smallpox vaccine and the drop in immunity against Orthopoxvirus
If you'd like to know more about the efficacy of our Clinell product range, please don't hesitate to contact us via our contact form. Help spread awareness of the virus by sharing this article on social media.
We discuss air as a predominant route of transmission and how eng…
Safe disinfection for your dental practice
In today's article, our Clinical Consultant, Martin Kiernan, shar…
In today's article, we discuss Dr. Evonne Curran's review of the …